This update was written automatically with AI from market data and news wire reports, and published without review by a person.
Key Takeaways
- OpenAI has officially ended its exclusive distribution era with Microsoft, bringing its frontier AI models to Google Cloud (GOOGL) to expand its enterprise reach.
- AT&T (T) shares plummeted 5.7% in premarket trading after the telecom giant missed analyst estimates for wireless postpaid subscriber additions.
- Abbott Laboratories (ABT) announced a major strategic shift, planning to spin off its Nutrition business into a standalone public company by 2027.
- NextEra Energy (NEE) beat third-quarter earnings expectations with an adjusted EPS of $1.24, while maintaining its full-year guidance at the high end of the $3.92 to $4.02 range.
- High-level diplomatic talks between Russian President Vladimir Putin and U.S. envoy Steve Witkoff concluded in St. Petersburg, with discussions focused on a potential ceasefire framework for the Ukraine conflict.
OpenAI Diversifies Cloud Partnerships
In a significant shift for the artificial intelligence landscape, OpenAI is making its latest frontier models, including GPT-6 Astra, available on Google Cloud (GOOGL). This move effectively ends OpenAI's exclusive distribution arrangement with Microsoft and follows a similar recent expansion to Amazon Web Services.
The partnership allows Google Cloud customers to purchase OpenAI models through the Google Cloud Marketplace and apply existing cloud spending commitments toward these tools. Industry analysts view this as a strategic pivot by OpenAI to capture a larger share of the enterprise market by meeting customers on their preferred infrastructure platforms.
Mixed Earnings Results Shake Major Caps
AT&T (T) saw its stock drop 5.7% premarket despite beating top and bottom-line estimates with $32.3 billion in revenue and $0.65 adjusted EPS. Investors reacted negatively to a miss in core wireless postpaid phone net additions, which came in at 379,000 against the 387,400 expected. The subscriber shortfall overshadowed the company's decision to raise its full-year profit forecast to $2.40 per share.
Abbott Laboratories (ABT) reported solid Q3 results with $13.01 billion in sales, but the headline was the planned spinoff of its $8.5 billion Nutrition unit. The company expects to complete the separation by late 2027, allowing its medical device and diagnostic segments to operate more leanly. Abbott reaffirmed its full-year adjusted EPS guidance of $5.50 to $5.55.
NextEra Energy (NEE) delivered a robust quarterly performance, reporting adjusted earnings of $2.59 billion, or $1.24 per share. While operating revenue of $8.09 billion fell short of the $8.5 billion estimate, the company's renewables backlog grew to a record 36.7 gigawatts. Management signaled confidence by targeting the high end of their annual earnings guidance.
Life Sciences and Geopolitical Developments
Thermo Fisher Scientific (TMO) reported a 9% increase in third-quarter revenue to $12.14 billion, beating the $11.95 billion consensus. The company saw adjusted operating margins expand to 24.5%, driven by strong demand in its laboratory products and biopharma services. Thermo Fisher expects full-year revenue to land between $47.7 billion and $48.2 billion.
On the geopolitical front, TASS reported that a five-hour meeting between Vladimir Putin and U.S. special envoy Steve Witkoff has concluded. Witkoff reportedly presented documents outlining U.S. approaches to ending the war in Ukraine and expressed hope for resuming trilateral negotiations. While no formal agreement was announced, the meeting's length and the presence of high-level aides suggest a serious exploratory phase in back-channel diplomacy.
Automated market updates written with AI from market data and news wire reports, published without human review.